Perampanel in Patients with a History of Psychiatric Illness: Post Hoc Analysis of Four Randomised Phase III Studies and their Open-Label Extensions

被引：0

作者：

Malhotra, Manoj ^{[1
]}

Patten, Anna ^{[2
]}

Kanner, Andres ^{[3
]}

机构：

[1] Eisai Inc, Woodcliff Lake, NJ USA

[2] Eisai Europe Ltd, Hatfield, Herts, England

[3] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

来源：

EPILEPSIA | 2021年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

253

引用

页码：57 / 57

页数：1

共 50 条

[41] Effect of Common Concomitant Antiepileptic Drugs (AEDs) During Adjunctive Treatment with Perampanel: Post Hoc Analysis from the Open- Label Extension (OLEx) of a Phase III Study in Patients with Idiopathic Generalized Epilepsy (IGE)
O'Brien, Terence J.
Bibbiani, Francesco
Patten, Anna
Laurenza, Antonio
Williams, Betsy
NEUROLOGY, 2018, 90
[42] AN EVALUATION OF DEPRESSIVE SYMPTOMS FOLLOWING TREATMENT WITH ESLICARBAZEPINE ACETATE: A POOLED ANALYSIS IN THE OPEN-LABEL EXTENSIONS OF THREE PHASE III STUDIES IN SUBJECTS WITH PARTIAL-ONSET SEIZURES
Almeida, Luis
Nunes, T.
Versavel, M.
Maia, J.
Soares-da-Silva, P.
EPILEPSIA, 2009, 50 : 120 - 120
[43] Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data
Citrome, Leslie
Volavka, Jan
Czobor, Pal
Brook, Shlomo
Loebel, Antony
Mandel, Francine S.
JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (04) : 638 - 642
[44] Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study
Ishigooka, Jun
Inada, Ken
Niidome, Kazunari
Aoki, Kazuo
Kojima, Yoshitsugu
Iwashita, Shuichi
Yamada, Sakiko
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (04)
[45] Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies
Saito, Yoji
Yokota, Takaaki
Arai, Masatsugu
Tada, Yukio
Sumitani, Masahiko
JOURNAL OF PAIN RESEARCH, 2019, 12 : 127 - 138
[46] Concomitant Drug Load Reduction During Adjunctive Cenobamate Therapy: Post-hoc Analysis of a Phase 3, Open-Label Study
Aboumatar, Sami
Ferrari, Louis
Stern, Sean
Wade, Clarence
Weingarten, Mindl
Connor, Gregory S.
Rosenfeld, William E.
NEUROLOGY, 2023, 100 (17)
[47] Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study
Abou-Khalil, Bassel
Aboumatar, Sami
Klein, Pavel
Krauss, Gregory L.
Sperling, Michael R.
Rosenfeld, William E.
EPILEPSY RESEARCH, 2022, 184
[48] Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies
Pina-Garza, J. Eric
Rosenfeld, William
Saeki, Kazunori
Villanueva, Vicente
Yoshinaga, Harumi
Patten, Anna
Williams, Betsy
Malhotra, Manoj
EPILEPSY & BEHAVIOR, 2020, 104
[49] Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomised, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal haemoglobinuria (PNH)
Schrezenmeier, Hubert
Kulasekararaj, Austin
Mitchell, Lindsay
de latour, Regis Peffault
Devos, Timothy
Okamoto, Shinichiro
Wells, Richard
Popoff, Evan
Cheung, Antoinette
Johnston, Karissa
Wang, Jimmy
Gustovic, Philippe
Wang, Alice
Tomazos, Ioannis
Patel, Yogesh
Lee, Jong Wook
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 136 - 137
[50] A prospective, multicenter, open-label phase III study of emicizumab prophylaxis in patients with acquired hemophilia A
Shima, Midori
Amano, Kagehiro
Ogawa, Yoshiyuki
Yoneyama, Koichiro
Ozaki, Ryoto
Kobayashi, Ryota
Sakaida, Emiko
Saito, Makoto
Okamura, Takashi
Ito, Toshihiro
Hattori, Norimichi
Higasa, Satoshi
Suzuki, Nobuaki
Seki, Yoshinobu
Nogami, Keiji
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (03) : 534 - 545

← 1 2 3 4 5 →